Trial Profile
A phase I trial of IONIS-FB-LRX in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Aug 2017
Price :
$35
*
At a glance
- Drugs IONIS FB LRX (Primary)
- Indications Age-related macular degeneration
- Focus Adverse reactions
- 17 Aug 2017 New trial record